Here's What Key Metrics Tell Us About MacroGenics (MGNX) Q3 Earnings

MacroGenics (MGNX) reported $110.71 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 964.5%. EPS of $0.90 for the same period compares to -$0.52 a year ago.The reported revenue represents a surprise of +14.09% over the Zacks Consensus Estimate of $97.04 million. With the consensus EPS estimate being $0.17, the EPS surprise was +429.41%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to ...